How clinical laboratories verify a new reagent lot under CLSI EP26 (2nd edition, 2022). The protocol, sample requirements, acceptance criteria, and documentation for lot-to-lot verification.
Frequently Asked Questions
Is reagent lot verification required by CLIA?
CLIA does not name a lot-to-lot patient comparison, but it requires the pieces that make one the usual practice. 42 CFR §493.1255(b)(3)(i) requires calibration verification when a complete change of reagents is introduced, unless the laboratory can demonstrate that changing reagent lot numbers does not affect the reportable range and control values, and §493.1256(d)(6) requires control testing before resuming patient testing. A documented lot comparison is how a laboratory makes that demonstration. CAP's All Common checklist requires new lots and shipments to be checked (COM.30450). The regulation does not prescribe the exact protocol or sample count, which the laboratory establishes with medical director or designee approval.
How many samples does EP26 require?
EP26 and CLIA do not set a fixed number. The medical director or designee determines it based on the analyte's risk and the laboratory's total allowable error (TEa). In practice, many laboratories adopt a minimum of about 20 patient samples spanning the analytical measuring range, the same floor commonly used for reference interval verification, and use more for higher-stakes analytes.
What is the difference between lot-to-lot verification and calibration verification?
Calibration verification confirms accuracy against known true values across the reportable range. Reagent lot-to-lot verification confirms that results from a new reagent lot agree with the current lot on patient samples. Calibration verification asks whether your results are correct; lot verification asks whether changing the reagent lot shifted your results. Different triggers, different question.
How do I set the acceptance criterion for a lot change?
The medical director or designee sets it, based on clinical need and the manufacturer's labeling, and documents why it fits. VeritaCheck® applies one rule to the total allowable error (TEa) the laboratory adopts: the study passes when the mean absolute percent difference between the two lots is within TEa and at least 90 percent of paired patient specimens are within TEa.
What do I do if a new reagent lot fails verification?
Treat it as an investigation, not an automatic rejection. Confirm the samples and inputs, repeat or expand the study, and look for an assignable cause such as calibration, control performance, or sample integrity. The final determination rests with the laboratory director or designee.
How often must I verify reagent lots?
CLIA's trigger is a complete change of reagents, unless the laboratory can demonstrate that changing lots has no effect (42 CFR §493.1255(b)(3)(i)). CAP has new lots and shipments checked before or concurrently with being placed in service (COM.30450), and a laboratory can require a check of every new lot by policy. It is event-driven, not a fixed calendar interval.